Molecular Cancer Research · 2008 · 38 citations · 39 references
Life SciencesCell BiologyOncologyCell ProliferationCell SignalingSignal TransductionCancer Cell SignalingCytokine Receptor SignalingGrowth Factor SignalingNeuroendocrine Control Of GrowthOncogenic Signaling PathwaysReceptor Tyrosine Kinase SignalingCellular ProliferationEndocrine Tumor MetastasisReceptor Protein Tyrosine PhosphatasesTransforming Growth Factor Beta Receptor SignalingTransforming Growth Factor Beta RegulationTransforming Growth Factor Beta Signaling ModulationTransforming Growth Factor-beta SignalingTumor Metastasis Biology
The dual effect of the ubiquitous inflammatory cytokine transforming growth factor beta1 (TGF beta) on cellular proliferation and tumor metastasis is intriguing but complex. In epithelial cell- and neural cell-derived tumors, TGF beta serves as a growth inhibitor at the beginning of tumor development but later becomes a growth accelerator for transformed tumors. The somatostatin (SST) signaling pathway is a well-established antiproliferation signal, and in this report, we explore the interplay between the SST and TGF beta signaling pathways in the human neuroendocrine tumor cell line BON. We defined the SST signaling pathway as a determinant for neuroendocrine tumor BON cells in responding to TGF beta as a growth inhibitor. We also determined that TGF beta induces the production of SST and potentially activates the negative growth autocrine loop of SST, which leads to the downstream induction of multiple growth inhibitory effectors: protein tyrosine phosphatases (i.e., SHPTP1 and SHPTP2), p21(Waf1/Cip1), and p27(Kip1). Concurrently, TGF beta down-regulates the growth accelerator c-Myc protein and, collectively, they establish a firm antiproliferation effect on BON cells. Additionally, any disruption in the activation of either the TGF beta or SST signaling pathway in BON leads to "reversible" neuroendocrine-mesenchymal transition, which is characterized by the loss of neuroendocrine markers (i.e., chromogranin A and PGP 9.5), as well as the altered expression of mesenchymal proteins (i.e., elevated vimentin and Twist and decreased E-cadherin), which has previously been associated with elevated metastatic potential. In summary, TGF beta-dependent growth inhibition and differentiation is mediated by the SST signaling pathway. Therefore, any disruption of this TGF beta-SST connection allows BON cells to respond to TGF beta as a growth accelerator instead of a growth suppressor. This model can potentially apply to other cell types that exhibit a similar interaction of these pathways.
39
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Jing Yang, Sendurai A. Mani, Joana Liu Donaher et al. · Cell · 2004 · 3.8K citations · Full text
Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
Paul Brazeau, Wylie Vale, Roger Burgus et al. · Science · 1973 · 3.5K citations
Jean Claude Reubi, Jean-Claude Schär, Beatrice Waser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 1.1K citations
Joan Seoane, Hông-Van Lê, Lijian Shen et al. · Cell · 2004 · 1K citations · Full text
Medicine, Cell Biology, Oncology +14